课题基金 / 基金详情

BIOLOGICAL ACTIVITIES OF CANNABINOIDS

BIOLOGICAL ACTIVITIES OF CANNABINOIDS
大麻素的生物活性
批准号:
3207107
负责人:
SUMNER HOWARD BURSTEIN
金额:
$16.12万
依托单位国家:
美国
项目类别:
财政年份:
1977
资助国家:
美国
项目状态:
已结题
起止时间:
1977-10-01 至 1994-03-31

项目摘要

项目成果

SUMNER HOWARD BURSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
该提案包含几个独立但相关的目标, 是从我们之前和正在进行的关于这种机制的研究中得出的 大麻素的作用。中心假设是THC和 其他大麻素对脂肪代谢有深远的影响,在 特别是花生四烯酸的代谢,它导致 在体外和体内生产的显著变化 二十碳二烯类化合物,如PGE2。在这个方案中,我们已经证明,虽然 一些大麻素可以作为激动剂,其他的可以作为 对抗者。 目前的提案将直接涉及可能的 大麻素的激动剂-拮抗剂相互作用 小鼠的嗜睡反应。THC及其相关污染物的相对水平 代表激动剂-拮抗剂对的酸性代谢物将 被测量并与组织中二十烷类化合物水平和 生物终点,如眩晕、止痛和抗浮肿 效果。建立这种互动关系将会有所帮助 解释一些对THC知之甚少的影响。再来一次 这些发现的后果将是一些糟糕的 了解THC的影响。这些发现的进一步后果 将是以更理性的方式对待 大麻类药物治疗用途的发展。 最后,我们将探讨大麻类物质是否可能通过 它们的膜具有改变性能的优点,可以用于 治疗由逆转录病毒引起的疾病的新方法 被称为艾滋病。将进行实验,以确定可耐受的剂量 非精神活性大麻素可以显著地使细胞流态化 活体内的膜。膜上的这种变化被认为是 降低逆转录病毒的传染性,导致适度 这种疾病的影响。
英文摘要
This proposal contains several independent but related goals which were derived from our previous and ongoing studies on the mechanism of action of cannabinoids. The central hypothesis is that THC and other cannabinoids exert profound effects on lipid metabolism, in particular, the metabolism of arachidonic acid which results in significant change both in vitro and in vivo in the production of eicosanoids such as PGE2. In this scheme we have shown that while some cannabinoids can behave as agonists, others can act as antagonists. The present proposal will directly address the question of possible agonist-antagonist interactions of cannabinoids in models such as the cataleptic response in mice. Relative levels of THC and its acid metabolites, which represent an agonist-antagonist pair, will be measured and compared with tissue levels of eicosanoids and with biological endpoints such as catalepsy, analgesia and anti-edema effects. The establishment of such an interaction would help explain some of the poorly understood effects of THC. A further consequence of these findings would be some of the poorly understood effects of THC. A further consequence of these findings would be a basis for a more rational approach toward the development of therapeutic uses for cannabinoids. Finally, we will explore the possibility that cannabinoids, by virtue of their membrane altering properties, could be used in a new approach to the treatment of diseases of retroviral origin such as AIDs. Experiments will be done to see whether tolerable doses of non-psychoactive cannabinoids can significantly fluidize cell membranes in vivo. Such changes in membranes are believed to decrease the infectivity of retroviruses resulting in a moderation of the effects of the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The elmiric acids: biologically active anandamide analogs.
The elmiric acids: biologically active anandamide analogs.
Endocannabinoid Analogs as Anti-inflammatory Agents
Endocannabinoid Analogs as Anti-inflammatory Agents
海外基金